Delivery Order SPE2DB20D3101-SPE2DB21FK3Y8
Award Date 8/30/21
Potential Completion Date 8/31/21
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award for the delivery of Ketorolac 30 mg/ml vials to the U.S. Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract has a ceiling value of $2,493.63 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,020.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,476,985 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial. The contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as...
- This is a $3,282.61 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Ketorolac 10mg tablets. The contract has an ultimate completion date of July 30, 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ketorolac 30 mg/mL vials. The $5,690.25 firm fixed price contract has a period of performance through March 8, 2023. The award is not designated as a set-aside and was made through full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. The contract has a potential value of $1,931.50 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of 25 units of Ketorolac 30mg/ml, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract, valued at $7,759.71, has a completion date of November 12, 2024. This award is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $2,530.98 to provide 4564108769 ketorolac 30 mg/ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,380.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,184.96 delivery order contract is for the supply of 4,562,953,214 units of Ketorolac 10 mg tablets. The contract has an ultimate completion date of December 1, 2023 and utilizes a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 30 mg/ml vials. The contract has a ceiling value of $16,221.75 and a period of performance through December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...